loadpatents
name:-0.025354862213135
name:-0.012166976928711
name:-0.0010759830474854
MOORE; Margaret Dow Patent Filings

MOORE; Margaret Dow

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOORE; Margaret Dow.The latest application filed is for "anti-il-22ra antibodies".

Company Profile
0.9.14
  • MOORE; Margaret Dow - Seattle WA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-il-22ra Antibodies
App 20130315919 - XU; Wenfeng ;   et al.
2013-11-28
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation
App 20120207761 - XU; Wenfeng ;   et al.
2012-08-16
Methods Of Treatment Using Anti-il-22ra Antibodies
App 20120156210 - XU; Wenfeng ;   et al.
2012-06-21
Methods of treatment using anti-IL-22RA antibodies
Grant 8,124,088 - Xu , et al. February 28, 2
2012-02-28
Trimerizing polypeptides
Grant 8,084,230 - Moore , et al. December 27, 2
2011-12-27
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
Grant 7,871,616 - Xu , et al. January 18, 2
2011-01-18
Trimerizing Polypeptides
App 20100297701 - Moore; Margaret Dow ;   et al.
2010-11-25
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation
App 20100210825 - XU; WENFENG ;   et al.
2010-08-19
Trimerizing polypeptides
Grant 7,655,439 - Moore , et al. February 2, 2
2010-02-02
Materials And Methods For Preparing Dimeric Growth Factors
App 20090280562 - Fox; Brian A. ;   et al.
2009-11-12
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation
App 20090220519 - Xu; Wenfeng ;   et al.
2009-09-03
Materials and methods for preparing dimeric growth factors
Grant 7,556,941 - Fox , et al. July 7, 2
2009-07-07
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
Grant 7,537,761 - Xu , et al. May 26, 2
2009-05-26
Trimerizing Polypeptides
App 20080220478 - Moore; Margaret Dow ;   et al.
2008-09-11
Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
Grant 7,262,025 - Moore August 28, 2
2007-08-28
Materials and methods for preparing dimeric growth factors
Grant 7,241,593 - Fox , et al. July 10, 2
2007-07-10
Materials And Methods For Preparing Dimeric Growth Factors
App 20070048828 - Fox; Brian A. ;   et al.
2007-03-01
Hybrid Vector Having A Cytomegalovirus Enhancer And Myeloproliferative Sarcoma Virus Promoter
App 20070042464 - Moore; Margaret Dow
2007-02-22
Dimerized PDGF-D and materials and methods for producing it
Grant 7,122,351 - Moore , et al. October 17, 2
2006-10-17
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
App 20060141582 - Xu; Wenfeng ;   et al.
2006-06-29
Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
App 20030232414 - Moore, Margaret Dow
2003-12-18
Materials and methods for preparing dimeric growth factors
App 20030224488 - Fox, Brian A. ;   et al.
2003-12-04
Dimerized growth factor and materials and methods for producing it
App 20030109000 - Moore, Margaret Dow ;   et al.
2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed